Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria Purpose

Clinical trial NCT01738945 · COMPLETED

Trial details

NCT number: NCT01738945
Sponsor: Gulhane School of Medicine
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

We Searched for the Effects of Calcium Channel Blocker Amlodipine on the Clinical and Laboratory Parameters of Diabetic Patients With Proteinuria.

Start date: 2008-02-01
Primary completion: 2009-05-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.